Fangsheng Pharmaceutical\'s announcement on holding a performance briefing for the third quarter of 2024
Fangsheng Pharmaceutical 2024 Semi-Annual Equity Distribution Implementation Notice
Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-037)
Fangsheng Pharmaceutical: Fangsheng Pharmaceutical\'s progress announcement on the transfer of part of the holding subsidiary\'s shares and the introduction of strategic investors
Fangsheng Pharmaceutical\'s progress announcement on the transfer of part of the holding subsidiary\'s shares and the introduction of strategic investors
Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-035, 36)
Fangsheng Pharmaceutical\'s dividend management system (reviewed and approved by the 2nd Extraordinary General Meeting of Shareholders in 2024)
Legal Opinion of Hunan Qiyuan Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Hunan Nansheng Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders of Fangsheng Pharmaceutical
Announcement of Fangsheng Pharmaceutical on participating in the 2024 Investor Online Group Reception Day in Hunan
Fangsheng Pharmaceutical\'s progress announcement on the transfer of part of the holding subsidiary\'s shares and the introduction of strategic investors
Announcement of Resolutions of the 7th Interim Meeting of the Fifth Supervisory Board of Fangsheng Pharmaceutical in 2024
Announcement of Fangsheng Pharmaceutical on the receipt of a notice of acceptance of drug registration by its wholly-owned subsidiary
Fangsheng Pharmaceutical: Fangsheng Pharmaceutical 2024 Second Extraordinary General Meeting of Shareholders Meeting Information
Fangsheng Pharmaceutical: Fangsheng Pharmaceutical\'s progress announcement on providing non-financial guarantees to subsidiaries
Fangsheng Pharmaceutical 2024 Second Extraordinary General Meeting of Shareholders Meeting Data
Fangsheng Pharmaceutical\'s progress announcement on providing non-financial guarantees for subsidiaries
Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-034)
Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-033)
Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-032)
No Data
No Data